Kineta is partnering with Genentech–Roche in an on-going research, option and licensing agreement to develop an antagonist of the α9/α10 nicotinic acetylcholine receptor (nAChR) for treatment ...

Research in our lab is focussed on identifying the signalling pathways and molecules controlling secretion from neurones and mast cells, with a special interest in voltage-gated (CaV), ligand-gated ...

“Sivanto® Prime is expected to be welcomed by growers. It delivers quick knockdown activity and has translaminar mobility to control a range of aphid species while featuring a favourable environmental ...